Document:

Exhibit 10.9

 

ABBOTT
LABORATORIES

RESTRICTED
STOCK AGREEMENT

 

This Restricted Stock
Agreement (the “Agreement”), made on «DateAwded»
(the “Grant Date”), between Abbott Laboratories, an Illinois corporation (the “Company”),
and «Name»  (the “Employee”),
provides for the grant by the Company to the Employee of a Restricted Stock
Award (the “Award”) under the Company’s 2009 Incentive Stock Program (the
“Program”).  This Agreement incorporates
and is subject to the provisions of the Program.  To the extent not defined herein, capitalized
terms shall have the same meaning as in the Program, and in the event of any
inconsistency between the provisions of this Agreement and the provisions of
the Program, the Program shall control.

 

The terms and conditions
of the Award are as follows:

 

1.       Grant of Shares.  Pursuant to
action of the Compensation Committee of the Board of Directors of the Company,
and in consideration of valuable services heretofore rendered and to be
rendered by the Employee to the Company and of the agreements hereinafter set
forth, the Company has granted to the Employee «NoShares12345» Shares.  The Shares shall be
issued from the Company’s available treasury shares.  The Employee shall have all the rights of a
shareholder with respect to the Shares, including the right to vote and to
receive all dividends or other distributions paid or made with respect to the
Shares.  However, the Shares (and any
securities of the Company which may be issued with respect to the Shares by
virtue of any stock split, combination, stock dividend or recapitalization,
which securities shall be deemed to be “Shares” hereunder) shall be subject to
all the restrictions hereinafter set forth.

 

2.       Restriction.  Until the
restriction imposed by this Section 2 (the “Restriction”) has lapsed
pursuant to Section 3 or 4 below, the Shares shall not be sold, exchanged,
assigned, transferred, pledged or otherwise disposed of, and shall be subject
to forfeiture as set forth in Section 5 below.

 

3.       Lapse of Restriction by Passage of Time.  The Restriction shall lapse and have no
further force on the third anniversary of the Grant Date.

 

4.       Lapse of Restriction Due to Death or Disability.  The Restriction shall lapse and have no
further force or effect upon the date of the Employee’s death or
disability.  For purposes of this
Agreement, the term “disability” shall mean the Employee’s disability as
defined in subsection 4.1(a) of the Abbott Laboratories Extended
Disability Plan for twelve consecutive months. 
Once the Employee has been disabled as defined in this Section for
twelve consecutive months, the disability shall be deemed to have occurred on
the first day of such twelve-month period.

 

5.       Forfeiture of Shares.  In the event of termination of the
Employee’s employment with the Company and its Subsidiaries, other than under the circumstances
described in Section 4 above, including, without limitation, due 

 

1

 

to the Employee’s
voluntary resignation (including retirement under a Company pension
plan) or involuntary
discharge for cause, any shares with respect to which the Restriction has not
lapsed as of the date of termination, shall be forfeited as of the date of
termination, without consideration to the Employee or the Employee’s executor,
administrator, personal representative or heirs (“Representative”), provided,
however, that in the event that the Employee is involuntarily discharged by the
Company and its
Subsidiaries other than for cause, the Company shall have the authority (but
not the obligation) to act, in its sole discretion, to accelerate the lapse of
the Restriction set forth in Section 3 above in whole or in part and to
cause some or all of the Shares that have not previously been paid out on a
Delivery Date set forth in Section 3 above to be settled in the form of
Shares on the date of such involuntary discharge.

 

6.       Withholding Taxes.  The Employee may satisfy any federal, state,
local or foreign taxes arising from delivery of the Shares pursuant to Section 3
or 4 above by (i) tendering a cash payment, (ii) having the Company
withhold Shares from the Shares to be delivered to satisfy the minimum
applicable withholding tax, (iii) tendering Shares received in connection
with the Award back to the Company, or (iv) delivering other previously
acquired Shares having a Fair Market Value approximately equal to the amount to
be withheld.  The Company shall have the
right and is hereby authorized to withhold from the Shares deliverable to the
Employee pursuant to Section 3 or 4 above or from any other compensation
or other amount owing to the Employee such amount as may be necessary in the
opinion of the Company to satisfy all such taxes, requirements and withholding
obligations.  If the Company withholds
from the Shares for tax purposes, the Employee is deemed to have been issued
the full number of Shares underlying the Award, notwithstanding that a number
of the Shares are held back solely for the purpose of satisfying any such
taxes, requirements and withholding obligations.

 

7.       No Right to
Continued Employment.  Neither the Program nor this Agreement shall
confer upon the Employee the right to continue in the employ or service of the
Company or any Subsidiary, to be entitled to any remuneration or benefits not
set forth in the Program or this Agreement or other agreement, or to interfere
with or limit in any way the right of the Company or any such Subsidiary to
terminate the Employee’s employment or service or to exercise any of the other rights
of the Company or its Subsidiaries under the Agreement.

 

8.       Data Privacy.  This grant of Shares shall be interpreted to
effect the original intent of the Company as closely as possible to the fullest
extent permitted by applicable law (including, without limitation, any laws governing
data privacy).  If any condition or
provision of this grant is invalid, illegal, or incapable of being enforced
under any applicable law or regulation governing data privacy, including the
privacy laws and regulations of the European Economic Area, all other conditions
and provisions of the Shares shall nevertheless remain in full force and
effect.  By accepting this grant, the
Employee voluntarily and unambiguously acknowledges and consents to the
collection, use, processing and transfer of Personal Data (defined below) as
described in this paragraph, in electronic or other form.  The 

 

2

 

Employee is not
obliged to consent to such collection, use, processing and transfer of Personal
Data.  However, failure to provide the
consent may affect the Employee’s ability to participate in the Program.  The Employee understands that the Company and
its Subsidiaries hold certain personal information about the Employee,
including, but not limited to, the Employee’s name, home address and telephone
number, date of birth, social security number or other employee identification
number, salary, nationality, job title, the number of Shares (if any) owned by
the Employee, whether the Employee is a member of the Board of Directors of the
Company or of any of its Subsidiaries, details of all stock options or any
other entitlement to Shares awarded, canceled, purchased, vested, unvested or
outstanding in the Employee’s favor for the purpose of managing and
administering the Program or this grant (collectively “Personal Data”).  The Employee understands that the Company and
its Subsidiaries will transfer Personal Data amongst themselves as necessary
for the purpose of implementation, administration and management of the
Employee’s participation in the Program, and the Company and/or any of its
Subsidiaries may each further transfer Personal Data to any third parties
assisting the Company in the implementation, administration and management of
the Program, including UBS or such other stock plan service provider as may be
selected by the Company in the future. 
These recipients may be located in the European Economic Area, or
elsewhere throughout the world, such as the United States and the recipients’
country (e.g., the United States) may have different data privacy laws and
protections than the Employee’s country. 
The Employee understands that the Employee may request a list with the
names and addresses of any potential recipients of the Personal Data by
contacting the local human resources representatives.  The Employee hereby authorizes the Company
and its Subsidiaries to receive, possess, use, retain and transfer the Personal
Data, in electronic or other form, for the purposes of implementing,
administering and managing the Employee’s participation in the Program,
including any transfer of such Personal Data as may be required for the
administration of the Program and/or the subsequent holding of Shares on the
Employee’s behalf to a broker or other third party with whom the Employee may
elect to deposit any Shares acquired pursuant to the Program.  The Employee understands that Personal Data
will be held only as long as is necessary to implement, administer and manage
the Employee’s participation in the Program. 
The Employee may, at any time, review Personal Data, request additional
information about the storage and processing of Personal Data, and require any
necessary amendments to it.  The Employee
may, at any time, withdraw the consents herein, in any case without cost, in
writing by contacting the Company; however, withdrawing the Employee’s consent
may affect the Employee’s ability to participate in the Program.

 

3

 

9.       Discharge for Cause.  The term
discharge “for cause” shall mean termination of the Employee’s employment with
the Company and its Subsidiaries for (A) the Employee’s failure to
substantially perform the duties of the Employee’s employment (other than any
such failure resulting from the Employee’s disability); (B) material
breach by the Employee of the terms and conditions of the Employee’s
employment; (C) material breach by the Employee of business ethics; (D) an
act of fraud, embezzlement or theft committed by the Employee in connection
with the Employee’s duties or in the course of the Employee’s employment; or (E) wrongful
disclosure by the Employee of secret processes or confidential information of
the Company or its Subsidiaries.

 

10.     Voting Rights; Payment of Dividends.  While the Restriction is in effect, the
Employee shall be entitled to vote the Shares granted hereunder and shall be
entitled to receive dividends paid on Shares to the same extent and on the same
date paid to the Company’s shareholders.

 

11.     Compliance with Applicable Laws and
Regulations.  Notwithstanding any other
provision of the Program or this Agreement to the contrary, the Company shall
not be required to issue or deliver any Shares pursuant to Section 3 or 4
above pending compliance with all applicable federal and state securities and
other laws (including any registration requirements or tax withholding
requirements) and compliance with the rules and practices of any stock
exchange upon which the Company’s Shares are listed.

 

12.     Section 409A.  To the extent applicable, it is intended that
this Agreement comply with, or be exempt from, the provisions of Code Section 409A.  The Agreement will be administered and
interpreted in a manner consistent with this intent, and any provision that
would cause the Agreement to fail to satisfy Code Section 409A will have
no force and effect until amended to comply therewith (which amendment may be
retroactive to the extent permitted by Code Section 409A).  Notwithstanding anything contained herein to
the contrary, for all purposes of this Agreement, the Employee shall not be
deemed to have had a termination of service unless the Employee has incurred a
separation from service as defined in Treasury Regulation §1.409A-1(h) and,
to the extent required to avoid accelerated taxation and/or tax penalties under
Code Section 409A and applicable guidance issued thereunder, amounts that
would otherwise be payable pursuant to the Agreement during the six-month
period immediately following the Employee’s termination of service
(including retirement) shall instead be paid on the first business day
after the date that is six months following the Employee’s termination of
service (or upon the Employee’s death, if earlier).  For purposes of this Agreement, “disability”
shall mean, as of a particular date, the Employee is, by reason of any
medically determinable physical or mental impairment that can be expected to
result in death or can be expected to last for a continuous period of not less
than twelve months, eligible to receive income replacement benefits under the
terms of the Abbott Laboratories Extended Disability Plan (“EDP”) or, for an
Employee whose employer does not participate in the EDP, such similar 

 

4

 

accident and
health plan, providing income replacement benefits, in which the Employee’s
employer participates, for a period of at least six months.

 

13.     Succession.  This Agreement shall be binding upon and
operate for the benefit of the Company and its successors and assigns, and the
Employee and the Employee’s Representative.

 

14.     Severability.  The invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability of
any other provision of this Agreement, and each other provision of the
Agreement shall be severable and enforceable to the extent permitted by
law.  To the extent a court or tribunal
of competent jurisdiction determines that any provision of this Agreement is
invalid or unenforceable, in whole or in part, the Company, in its sole discretion,
shall have the power and authority to revise or strike such provision to the
minimum extent necessary to make it valid and enforceable to the full extent
permitted under local law.

 

15.     Governing Law. 
This Agreement shall be governed by and construed in accordance with the
laws of the State of Illinois without giving effect to the conflict of laws
principles thereof.

 

IN WITNESS WHEREOF, the
Company has caused this Agreement to be executed by its duly authorized officer
as of the grant date above set forth.

 

 

	
   

  	
   

  	
  ABBOTT LABORATORIES

  
	
   

  	
   

  
	
   

  	
  By

  	
  

  
	
   

  	
   

  
	
   

  	
   

  	
  Miles D. White

  
	
   

  	
   

  	
  Chairman and
  Chief Executive Officer

  

 

5Exhibit 10.10

 

ABBOTT LABORATORIES

PERFORMANCE RESTRICTED STOCK AGREEMENT

 

This
Performance Restricted Stock Agreement (the “Agreement”), made on «DateAwded» (the “Grant Date”), between
Abbott Laboratories, an Illinois corporation (the “Company”), and «Name» (the “Employee”), provides for the
grant by the Company to the Employee of a Performance Restricted Stock Award
(the “Award”) under the Company’s 2009 Incentive Stock Program (the “Program”). 
This Agreement incorporates and is subject to the provisions of the
Program.  To the extent not defined
herein, capitalized terms shall have the same meaning as in the Program, and in
the event of any inconsistency between the provisions of this Agreement and the
provisions of the Program, the Program shall control.

 

The
terms and conditions of the Award are as follows:

 

1.       Grant
of Shares.  Pursuant to action of the
Compensation Committee of the Board of Directors of the Company, and in
consideration of valuable services heretofore rendered and to be rendered by the
Employee to the Company and of the agreements hereinafter set forth, the
Company has granted to the Employee «NoShares12345»
Shares.  The Shares shall be issued from the Company’s available treasury
shares.  The Employee shall have all the rights of a shareholder with
respect to the Shares, including the right to vote and to receive all dividends
or other distributions paid or made with respect to the Shares.  However,
the Shares (and any securities of the Company which may be issued with respect
to the Shares by virtue of any stock split, combination, stock dividend or
recapitalization, which securities shall be deemed to be “Shares” hereunder)
shall be subject to all the restrictions hereinafter set forth.

 

2.       Restriction.  Until the restriction imposed by this Section 2
(the “Restriction”) has lapsed pursuant to Section 3 or 4 below, the
Shares shall not be sold, exchanged, assigned, transferred, pledged or
otherwise disposed of, and shall be subject to forfeiture as set forth in Section 5
below.

 

3.       Lapse
of Restriction Based on Performance.  The
restrictions on one-third of the total number of Shares will lapse and have no
further force on the last business day of February, 2010, provided that the
Company’s prior year Return on Equity is a minimum of 18 percent; the
restrictions on an additional one-third of the total number of Shares will
lapse and have no further force on the last business day of February, 2011,
provided that the Company’s prior year Return on Equity is a minimum of 18
percent; the restrictions on the remaining one-third of the total number of
Shares will lapse and have no further force on the last business day of
February, 2012, provided that the Company’s prior year Return on Equity is a
minimum of 18 percent.  Notwithstanding the foregoing, any remaining
Shares that have not previously vested in 2010, 2011 or 2012 shall remain
outstanding and shall vest on the last business day of February, 2013 and/or
2014, provided that the Company’s prior year Return on Equity is a minimum of
18 percent, and provided further that no more than one-third of the Shares will
vest in any one year.

 

1

 

4.       Retirement.  The Restriction shall continue to apply (and
may lapse in accordance with the provisions of Section 3 above) in the
event that the Employee’s employment with the Company and its Subsidiaries is
terminated by the Employee due to retirement.

 

5.       Lapse
of Restriction Due to Death or Disability. 
The Restriction shall lapse and have no further force or effect upon the
date of the Employee’s death or disability. For purposes of this Agreement, the term “disability” shall mean the
Employee’s disability as defined in subsection 4.1(a) of the Abbott
Laboratories Extended Disability Plan for twelve consecutive months.  Once the Employee has been disabled as
defined in this Section for twelve consecutive months, the disability
shall be deemed to have occurred on the first day of such twelve-month period.

 

6.       Forfeiture
of Shares.  In the event of termination
of the Employee’s employment with the Company and its Subsidiaries, other than
under the circumstances described in Section 4 or Section 5 above,
(including, without limitation, due to the Employee’s voluntary resignation
(other than due to retirement) or involuntary discharge for cause), any Shares
with respect to which the Restriction has not lapsed as of the date of
termination shall be forfeited as of the date of termination, without
consideration to the Employee or the Employee’s executor, administrator,
personal representative or heirs (“Representative”), provided, however, that in
the event that the Employee is involuntarily discharged by the Company and its
Subsidiaries other than for cause, the Company shall have the authority (but
not the obligation) to act, in its sole discretion, to accelerate the lapse of
the Restriction set forth in Section 3 above in whole or in part and to
cause some or all of the Shares that have not previously been paid out on a
Delivery Date set forth in Section 3 above to be settled in the form of
Shares on the date of such involuntary discharge.  The term discharge “for cause” shall have the
meaning given that term by Section 9.

 

7.       Withholding
Taxes.  The Employee may satisfy any
federal, state, local or foreign taxes arising from delivery of the Shares
pursuant to Section 3, 4, or 5 above by (i) tendering a cash payment,
(ii) having the Company withhold Shares from the Shares to be delivered to
satisfy the minimum applicable withholding tax, (iii) tendering Shares
received in connection with the Award back to the Company, or (iv) delivering
other previously acquired Shares having a Fair Market Value approximately equal
to the amount to be withheld.  The
Company shall have the right and is hereby authorized to withhold from the
Shares deliverable to the Employee pursuant to Section 3, 4, or 5 above or
from any other compensation or other amount owing to the Employee such amount
as may be necessary in the opinion of the Company to satisfy all such taxes,
requirements and withholding obligations. 
If the Company withholds from the Shares for tax purposes, the Employee
is deemed to have been issued the full number of Shares underlying the Award,
notwithstanding that a number of the Shares are held back solely for the
purpose of satisfying any such taxes, requirements and withholding obligations.

 

8.       No Right to Continued Employment.  Neither the Program nor this Agreement shall
confer upon the Employee the right to continue in the employ or service of the
Company or any Subsidiary, to be entitled to any 

 

2

 

remuneration or benefits not set forth in the
Program or this Agreement or other agreement, or to interfere with or limit in
any way the right of the Company or any such Subsidiary to terminate the
Employee’s employment or service or to exercise any of the other rights
of the Company or its Subsidiaries under the Agreement.

 

9.       Discharge
for Cause.  The term discharge “for cause”
shall mean termination of the Employee’s employment with the Company and its
Subsidiaries for (A) the Employee’s failure to substantially perform the
duties of the Employee’s employment (other than any such failure resulting from
the Employee’s disability); (B) material breach by the Employee of the
terms and conditions of the Employee’s employment; (C) material breach by
the Employee of business ethics; (D) an act of fraud, embezzlement or
theft committed by the Employee in connection with the Employee’s duties or in
the course of the Employee’s employment; or (E) wrongful disclosure by the
Employee of secret processes or confidential information of the Company or its
Subsidiaries.

 

10.     Voting
Rights; Payment of Dividends.  While the
Restriction is in effect, the Employee shall be entitled to vote the Shares
granted hereunder and shall be entitled to receive dividends paid on Shares to
the same extent and on the same date paid to the Company’s shareholders.

 

11.     Compliance
with Applicable Laws and Regulations. 
Notwithstanding any other provision of the Program or this Agreement to
the contrary, the Company shall not be required to issue or deliver any Shares
pursuant to Section 3, 4, or 5 above pending compliance with all
applicable federal and state securities and other laws (including any
registration requirements or tax withholding requirements) and compliance with
the rules and practices of any stock exchange upon which the Company’s
Shares are listed.

 

12.     Construction.  This Award is intended to qualify as
qualified performance-based compensation under Section 162(m) of the
Internal Revenue Code of 1986, as amended, to the extent applicable.  This
Agreement shall be construed accordingly.

 

13.     Data
Privacy.  This grant of Shares shall be
interpreted to effect the original intent of the Company as closely as possible
to the fullest extent permitted by applicable law (including, without
limitation, any laws governing data privacy). 
If any condition or provision of this grant is invalid, illegal, or
incapable of being enforced under any applicable law or regulation governing
data privacy, including the privacy laws and regulations of the European
Economic Area, all other conditions and provisions of the Shares shall
nevertheless remain in full force and effect. 
By accepting this grant, the Employee voluntarily and unambiguously
acknowledges and consents to the collection, use, processing and transfer of
Personal Data (defined below) as described in this paragraph, in electronic or
other form.  The Employee is not obliged
to consent to such collection, use, processing and transfer of Personal
Data.  However, failure to provide the
consent may affect the 

 

3

 

Employee’s ability to participate in the
Program.  The Employee understands that
the Company and its Subsidiaries hold certain personal information about the
Employee, including, but not limited to, the Employee’s name, home address and
telephone number, date of birth, social security number or other employee
identification number, salary, nationality, job title, the number of Shares (if
any) owned by the Employee, whether the Employee is a member of the Board of
Directors of the Company or of any of its Subsidiaries, details of all stock
options or any other entitlement to Shares awarded, canceled, purchased,
vested, unvested or outstanding in the Employee’s favor for the purpose of
managing and administering the Program or this grant (collectively “Personal
Data”).  The Employee understands that
the Company and its Subsidiaries will transfer Personal Data amongst themselves
as necessary for the purpose of implementation, administration and management
of the Employee’s participation in the Program, and the Company and/or any of
its Subsidiaries may each further transfer Personal Data to any third parties
assisting the Company in the implementation, administration and management of
the Program, including UBS or such other stock plan service provider as may be
selected by the Company in the future. 
These recipients may be located in the European Economic Area, or
elsewhere throughout the world, such as the United States and the recipients’
country (e.g., the United States) may have different data privacy laws and
protections than the Employee’s country. 
The Employee understands that the Employee may request a list with the
names and addresses of any potential recipients of the Personal Data by
contacting the local human resources representatives.  The Employee hereby authorizes the Company
and its Subsidiaries to receive, possess, use, retain and transfer the Personal
Data, in electronic or other form, for the purposes of implementing,
administering and managing the Employee’s participation in the Program,
including any transfer of such Personal Data as may be required for the
administration of the Program and/or the subsequent holding of Shares on the
Employee’s behalf to a broker or other third party with whom the Employee may
elect to deposit any Shares acquired pursuant to the Program.  The Employee understands that Personal Data
will be held only as long as is necessary to implement, administer and manage
the Employee’s participation in the Program. 
The Employee may, at any time, review Personal Data, request additional
information about the storage and processing of Personal Data, and require any
necessary amendments to it.  The Employee
may, at any time, withdraw the consents herein, in any case without cost, in
writing by contacting the Company; however, withdrawing the Employee’s consent
may affect the Employee’s ability to participate in the Program.

 

14.     Succession.  This Agreement shall be binding upon and
operate for the benefit of the Company and its successors and assigns, and the
Employee and the Employee’s Representative.

 

15.     Section 409A.  To the extent
applicable, it is intended that this Agreement comply with, or be exempt
from, the provisions of Code Section 409A. 
The Agreement will be administered and interpreted in a manner
consistent with this intent, and any provision that would cause the Agreement
to fail to satisfy Code Section 409A will have no force and effect until
amended to comply therewith (which amendment may be retroactive to the extent 

 

4

 

permitted by Code Section 409A).  Notwithstanding anything contained herein to
the contrary, for all purposes of this Agreement, the Employee shall not be
deemed to have had a termination of service unless the Employee has incurred a
separation from service as defined in Treasury Regulation §1.409A-1(h) and,
to the extent required to avoid accelerated taxation and/or tax penalties under
Code Section 409A and applicable guidance issued thereunder, amounts that
would otherwise be payable pursuant to the Agreement during the six-month
period immediately following the Employee’s termination of service (including retirement)
shall instead be paid on the first business day after the date that is six
months following the Employee’s termination of service (or upon the Employee’s
death, if earlier).  For purposes
of this Agreement, “disability” shall mean, as of a particular date, the
Employee is, by reason of any medically determinable physical or mental
impairment that can be expected to result in death or can be expected to last
for a continuous period of not less than twelve months, eligible to receive income
replacement benefits under the terms of the Abbott Laboratories Extended
Disability Plan (“EDP”) or, for an Employee whose employer does not participate
in the EDP, such similar accident and health plan, providing income replacement
benefits, in which the Employee’s employer participates, for a period of at
least six months.

 

16.     Severability.  The invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability of
any other provision of this Agreement, and each other provision of the
Agreement shall be severable and enforceable to the extent permitted by
law.  To the extent a court or tribunal
of competent jurisdiction determines that any provision of this Agreement is
invalid or unenforceable, in whole or in part, the Company, in its sole
discretion, shall have the power and authority to revise or strike such
provision to the minimum extent necessary to make it valid and enforceable to
the full extent permitted under local law.

 

17.     Governing Law. 
This Agreement shall be governed by and construed in accordance with the
laws of the State of Illinois without giving effect to the conflict of laws
principles thereof.

 

IN WITNESS
WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer as of the grant date above set forth.

 

	
   

  	
   

  	
  ABBOTT LABORATORIES

  
	
   

  	
   

  
	
   

  	
  By

  	
  

  
	
   

  	
   

  
	
   

  	
   

  	
  Miles D. White

  
	
   

  	
   

  	
  Chairman and Chief Executive Officer

  

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]